RhumbLine Advisers’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17M | Buy |
131,978
+4,951
| +4% | +$43.8K | ﹤0.01% | 2167 |
|
|
2025
Q1 | $995K | Buy |
127,027
+2,890
| +2% | +$22.6K | ﹤0.01% | 2173 |
|
|
2024
Q4 | $1.3M | Buy |
124,137
+2,492
| +2% | +$26.2K | ﹤0.01% | 2106 |
|
|
2024
Q3 | $1.6M | Sell |
121,645
-1,030
| -0.8% | -$13.5K | ﹤0.01% | 2026 |
|
|
2024
Q2 | $1.72M | Buy |
122,675
+121,130
| +7,840% | +$1.7M | ﹤0.01% | 1963 |
|
|
2024
Q1 | $26.1K | Buy |
1,545
+289
| +23% | +$4.88K | ﹤0.01% | 3731 |
|
|
2023
Q4 | $17.7K | Hold |
1,256
| – | – | ﹤0.01% | 3787 |
|
|
2023
Q3 | $12.9K | Sell |
1,256
-65
| -5% | -$669 | ﹤0.01% | 3835 |
|
|
2023
Q2 | $21.8K | Buy |
+1,321
| New | +$21.8K | ﹤0.01% | 3800 |
|